In the news logo

In the News… Vertex buys Viacyte, Tandem mobile bolus begins roll out, a One Drop sensor and more!

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/23750015/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/3e9ccc/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_494_Final_In_the_news.mp3″ libsyn_item_id=”23750015″ height=”90″ theme=”custom” custom_color=”3e9ccc” player_use_thumbnail=”use_thumbnail” use_download_link=”use_download_link” download_link_text=”Download” /]Top stories in this news this week: Stem cell research Vertex company buys Viacyte, another company looking at stem cells for a functional cure for T1D, some tslim users are getting access to Tandem’s new mobile bolus feature, One Drop…